Antiepileptics: calming the storm
A seizure is a burst of synchronised, runaway electrical activity — too many neurons firing together. An antiepileptic tames it in one of two complementary ways: by damping excitation or by boosting inhibition. Many block sodium ion channels, the gates a neuron uses to fire repeatedly; with the gate sticky, a neuron can't keep firing in a runaway burst. Others enhance GABA, the calming messenger from guide 2 — the same braking system, used here to stop seizures.
Parkinson's: putting dopamine back
Parkinson's disease is the opposite problem: the brain's motor pathway loses the cells that make dopamine, so movement becomes slow, stiff, and tremulous. The obvious fix — give dopamine — fails, because dopamine cannot cross the blood–brain barrier. So we give its precursor instead. Levodopa is a prodrug: it does cross into the brain, where an enzyme converts it into dopamine. The active metabolite is the dopamine the brain was missing.
There is a catch. The same converting enzyme is busy in the rest of the body, turning levodopa into dopamine before it reaches the brain — wasting most of the dose and causing nausea. The elegant solution: pair levodopa with a second drug that blocks that enzyme only in the body (it cannot enter the brain). More levodopa survives the journey, so a smaller dose works with fewer side effects.
- Dopamine itself can't enter the brain, so it can't be given directly.
- Levodopa, its precursor, does cross the blood–brain barrier.
- Inside the brain, an enzyme converts levodopa into dopamine — the missing messenger.
- A peripheral enzyme blocker is added so more levodopa reaches the brain, cutting the dose and the nausea.
Two diseases, one logic
Notice the symmetry that closes this track. Epilepsy is too much firing, so we quiet the system — exactly the GABA-boosting logic of the sedatives in guide 2. Parkinson's is too little dopamine, so we restore it — the mirror image of the antipsychotics in guide 4, which deliberately turn dopamine down. Every CNS drug you have met is some version of one question: is there too much of a signal, or too little, and which step do we nudge to fix it?
CNS pharmacology in one frame:
TOO MUCH signal -> quiet it
epilepsy -> block Na+ channels / boost GABA
anxiety -> benzodiazepines boost GABA
psychosis -> block dopamine D2
TOO LITTLE signal -> restore it
depression -> SSRI raises serotonin
Parkinson's -> levodopa restores dopamine
Always ask: which step (release / receptor / clearance) do we nudge?